Sichenzia Ross Friedman Ference LLP Advises Intellect Neurosciences, Inc. on $1.2 Million PIPE offering
New York, July 31, 2014 (Global Newswire) – New York based securities law firm, Sichenzia Ross Friedman Ference LLP announced that it has represented Intellect Neurosciences, Inc. (ILNS: OTC US) on a $1.2 million private placement consisting of Series F Preferred Stock and Warrants. Intellect Neurosciences Inc. is a biopharmaceutical company engaged in the discovery and development of disease modifying therapeutic agents for the treatment and prevention of Alzheimer’s disease. The Sichenzia Ross Friedman Ference LLP team was led by partner Arthur Marcus.
- Sichenzia Ross Ference LLP Announces Over 80 Capital Markets Transactions Valued Over $2 Billion at the Closing of 2021 - January 13, 2022
- Sichenzia Ross Ference LLP Adds Two Key Additions to its Corporate and Securities Law Team - January 11, 2022
- Sichenzia Ross Ference LLP Represents Aegis Capital Corp. in $9.8 Million Underwritten Offering of BiondVax Pharmaceuticals Ltd. - December 30, 2021